# CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)

> **NCT04748861** · NA · ACTIVE_NOT_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 150 (actual)

## Conditions studied

- High Intensity Exercise
- Normal Cognition
- Exercise Intervention

## Interventions

- **OTHER:** Indoor Cycling (IC)

## Key facts

- **NCT ID:** NCT04748861
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748861, "CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04748861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*